Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS)

32.58 +0.16 (+0.49%) At close: 03:00PM CST

Tibet Rhodiola Pharmaceutical Holding Co.

Lhasa Economic and Tech Dev Zn
No. 3, Guangzhou Road Area A
Lhasa 850000
China
86 89 1683 6521
https://www.xzyy.cn

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 601

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Yuan Dong Guo	GM & Director	N/A	N/A	1972
Mr. Jun Chen	Financial Director	N/A	N/A	1978
Ms. Lan Liu	Deputy GM & Secretary of the Board	N/A	N/A	1969

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Tibet Rhodiola Pharmaceutical Holding Co. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. It offers biological products, Tibetan medicine, Chinese medicine, and chemical medicine products. The company was founded in 1999 and is based in Lhasa, China.

Corporate governance

Tibet Rhodiola Pharmaceutical Holding Co.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.